Precision Optics Schedules Second Quarter of Fiscal Year 2025 Conference Call for February 13, 2025
Precision Optics (Nasdaq: POCI), a designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has scheduled a conference call to discuss its second quarter fiscal year 2025 financial results on Thursday, February 13, 2025, at 5:00 p.m. ET.
The company will release its financial results and file its 10-Q after market close on the same day. Interested parties can join via phone at (844) 735-3662 or (412) 317-5705, or through a live webcast at https://app.webinar.net/z0E94DknxQO. A seven-day replay will be available through phone and webcast.
Precision Optics (Nasdaq: POCI), un progettista e produttore di strumenti ottici avanzati per le industrie mediche e della difesa/aerospaziali, ha programmato una call per discutere i risultati finanziari del secondo trimestre dell'anno fiscale 2025 il giovedì 13 febbraio 2025, alle 17:00 ET.
La compagnia rilascerà i suoi risultati finanziari e presenterà il suo 10-Q dopo la chiusura del mercato lo stesso giorno. Le parti interessate possono partecipare telefonicamente al numero (844) 735-3662 o (412) 317-5705, oppure tramite un webcast dal vivo all'indirizzo https://app.webinar.net/z0E94DknxQO. Un replay di sette giorni sarà disponibile tramite telefono e webcast.
Precision Optics (Nasdaq: POCI), un diseñador y fabricante de instrumentos ópticos avanzados para las industrias médica y de defensa/aeroespacial, ha programado una llamada de conferencia para discutir sus resultados financieros del segundo trimestre del año fiscal 2025 el jueves 13 de febrero de 2025, a las 5:00 p.m. ET.
La empresa publicará sus resultados financieros y presentará su 10-Q después del cierre del mercado el mismo día. Las partes interesadas pueden unirse por teléfono al (844) 735-3662 o (412) 317-5705, o a través de un webcast en vivo en https://app.webinar.net/z0E94DknxQO. Habrá una repetición de siete días disponible a través de teléfono y webcast.
프리시전 옵틱스 (Nasdaq: POCI)는 의료 및 방산/우주 산업을 위한 고급 광학 기기를 설계하고 제조하는 회사로, 2025 회계연도 2분기 재무 결과를 논의하기 위해 2025년 2월 13일 목요일 오후 5:00 ET에 컨퍼런스 콜을 일정에 넣었습니다.
회사는 같은 날 시장 종료 후 재무 결과를 발표하고 10-Q를 제출할 것입니다. 관심 있는 당사자는 (844) 735-3662 또는 (412) 317-5705로 전화 참여하거나 https://app.webinar.net/z0E94DknxQO에서 라이브 웹캐스트를 통해 참여할 수 있습니다. 7일간의 재생이 전화와 웹캐스트를 통해 제공됩니다.
Precision Optics (Nasdaq: POCI), un concepteur et fabricant d'instruments optiques avancés pour les secteurs médical et de la défense/aérospatial, a programmé une conférence téléphonique pour discuter de ses résultats financiers du deuxième trimestre de l'année fiscale 2025 le jeudi 13 février 2025, à 17h00 ET.
L'entreprise publiera ses résultats financiers et déposera son 10-Q après la clôture du marché le même jour. Les parties intéressées peuvent rejoindre par téléphone au (844) 735-3662 ou (412) 317-5705, ou par le biais d'un webinaire en direct à l'adresse https://app.webinar.net/z0E94DknxQO. Un replay de sept jours sera disponible par téléphone et webinaire.
Precision Optics (Nasdaq: POCI), ein Designer und Hersteller von fortschrittlichen optischen Instrumenten für die medizinische sowie die Verteidigungs-/Luftfahrtindustrie, hat eine Telefonkonferenz angesetzt, um die Finanzergebnisse des zweiten Quartals des Geschäftsjahres 2025 am Donnerstag, den 13. Februar 2025, um 17:00 Uhr ET zu besprechen.
Das Unternehmen wird seine finanziellen Ergebnisse nach Marktschluss am selben Tag veröffentlichen und seinen 10-Q einreichen. Interessierte Parteien können telefonisch unter (844) 735-3662 oder (412) 317-5705 teilnehmen oder über einen Live-Webcast unter https://app.webinar.net/z0E94DknxQO. Ein siebendämoniger Replay wird telefonisch und über den Webcast verfügbar sein.
- None.
- None.
GARDNER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s second quarter fiscal year 2025 financial results on Thursday, February 13, 2025, at 5:00 p.m. ET.
The Company intends to release its financial results and to file its 10-Q after the close of the market on Thursday, February 13, 2025, followed by the conference call.
Conference Call Details
Date and Time: Thursday, February 13, 2025, at 5:00 p.m. ET.
Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or (412) 317-5705.
Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available at https://app.webinar.net/z0E94DknxQO.
Replay: A teleconference replay of the call will be available for seven days, at (877) 344-7529 or (412) 317-0088, replay access code 5819695. A webcast replay will be available at https://app.webinar.net/z0E94DknxQO.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, electronic imaging expertise, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company designs and manufactures next-generation product solutions for the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery, including single-use medical devices, as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies with a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements which express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement, except as required by law.
Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com
FAQ
When will Precision Optics (POCI) release its Q2 2025 earnings?
How can investors join POCI's Q2 2025 earnings call?
How long will POCI's Q2 2025 earnings call replay be available?
What industries does Precision Optics (POCI) serve?
